Children’s Hospital of Philadelphia – Beckwith-Wiedemann Syndrome

Access Program Information

This purpose of this study is to determine the ability of an
18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET scan to detect a focal lesion of
hyperinsulinism and determine the location in patients with congenital hyperinsulinism,
Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected.